Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Jeisys Medical (287410 KS)
Watchlist
50
Analysis
Health Care
•
South Korea
Jeisys Medical Inc. operates medical device manufacturing businesses. The Company produces diagnostic devices, earpieces, rehabilitation devices, and other medical devices. Jeisys Medical conducts businesses in South Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Jeisys Medical
•
20 Aug 2024 01:07
Archimed Group Seeks Delisting of Jeisys Medical Through Stock Exchange
Jeisys Medical announced it has decided to exchange shares with Syracus Subco. Through this stock exchange, Archimed Group (owner of Syracus Subco)...
Douglas Kim
Follow
660 Views
Share
bullish
•
CK Infrastructure
•
18 Aug 2024 07:00
Last Week in Event SPACE: Aussie Tax Loss Basket, CK Infra, JTower, Porsche
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
548 Views
Share
bullish
•
China Traditional Chinese Medicine
•
17 Aug 2024 15:00
(Mostly) Asia-Pac M&A: TCM, BusinessOn Comm, Orora, Ramsay Health Care, Namoi Cotton, APM, CPMC
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
709 Views
Share
bullish
•
BusinessOn Communication
•
12 Aug 2024 16:41
Tender Offer of BusinessOn Communications by Skylake Equity Partners
On 12 August, Skylake Equity Partners announced a tender offer of 6.58 million shares (28.9% stake) of BusinessOn Communication. The tender offer...
Douglas Kim
Follow
505 Views
Share
bullish
•
Fuji Soft Inc
•
10 Aug 2024 15:00
(Mostly) Asia-Pac M&A: Fuji Soft, C.I. TAKIRON, Pacific Smiles, GaPack, Asia Cement, Shinko Electric
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
643 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x